Psychophysical Olfactory Outcomes After Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis
- 28 March 2026
- journal article
- review article
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 26 (1)
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Superior Benefits of Combining Mepolizumab With Sinus Surgery Compared to Mepolizumab Alone: Results From a Randomised 6‐Month TrialInternational Forum of Allergy & Rhinology, 2025
- Clinical Effects and Response Time of Biological Drugs in Chronic Rhinosinusitis with Nasal Polyps Patients: Real‐life ExperienceThe Laryngoscope, 2024
- Influence of Single Nucleotide Polymorphisms on CRS Outcomes: A Preliminary Observational StudyThe Laryngoscope, 2024
- Efficacy of dupilumab in real-life settings: a STROBE studyEuropean Archives of Oto-Rhino-Laryngology, 2024
- Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsOtolaryngology–Head and Neck Surgery, 2023
- Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled studyEuropean Archives of Oto-Rhino-Laryngology, 2023
- Dupilumab (Dupixent®) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in GermanyEuropean Archives of Oto-Rhino-Laryngology, 2022
- Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal PolyposisThe Laryngoscope, 2021
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal PolyposisJAMA, 2016
- Long‐term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitisThe Laryngoscope, 2009